Waldenstrom macroglobulinemia


Also found in: Dictionary.

Wal·den·ström mac·ro·glob·u·lin·e·mi·a

(vahld'ĕn-strum),
macroglobulinemia occurring in old people, characterized by proliferation of cells resembling lymphocytes or plasma cells in the bone marrow, anemia, increased sedimentation rate, and hyperglobulinemia with a narrow peak in γ-globulin or β2-globulin at about 19 S units. The spleen, liver, or lymph nodes are often enlarged with frequent purpura or mucosal bleeding.

Wal·den·ström mac·ro·glob·u·li·ne·mi·a

(vahl'den-strem mak'rō-glob'yū-li-nē'mē-ă)
Macroglobulinemia occurring in old people, characterized by proliferation of cells resembling lymphocytes or plasma cells in the bone marrow, anemia, an increased sedimentation rate, and hyperglobulinemia with a narrow peak in γ-globulin or β2-globulin at about 19 S units. The spleen, liver, and lymph nodes are often enlarged, and there is frequently purpura or mucosal bleeding.

Waldenström,

Jan G., Swedish physician, 1906–.
Waldenström macroglobulinemia - Synonym(s): hyperglobulinemic purpura; Waldenström purpura; Waldenström syndrome
Waldenström purpura - Synonym(s): Waldenström macroglobulinemia
Waldenström syndrome - Synonym(s): Waldenström macroglobulinemia
Waldenström test - a test for porphyrin in the urine.
References in periodicals archive ?
Janssen Research & Development, a subsidiary of Johnson & Johnson, has indicated improved progression-free survival in patients with Waldenstrom macroglobulinemia (WM), a form of non-Hodgkin's lymphoma, when administered with a combination of Imbruvica (ibrutinib) and rituximab (Rituxan) in its Phase three iNNOVATE (PCYC-1127) study, it was reported yesterday.
Case 2 was an 88-year-old man with a clinical history of Waldenstrom macroglobulinemia who was undergoing treatment with thalidomide.
Bone marrow cancers such as multiple myeloma and Waldenstrom macroglobulinemia often cause a person to have too much of one type of immunoglobulin in the blood.
Hyperviscosity-related retinopathy in waldenstrom macroglobulinemia.
AL-type amyloidosis can occur alone and it can be associated with lymphoproliferative disorders such as multiple myeloma or Waldenstrom macroglobulinemia.
Approximately 10-15 % of patients with myeloma or Waldenstrom macroglobulinemia develop systemic AL.
population and has long been thought to be a precursor of serious diseases, such as multiple myeloma, primary amyloidosis, and Waldenstrom macroglobulinemia.
Waldenstrom Macroglobulinemia Global Clinical Trials Review, H2, 2012" provides data on the Waldenstrom Macroglobulinemia clinical trial scenario.
It also reviews key players involved in the therapeutic development for Waldenstrom Macroglobulinemia and special features on late-stage and discontinued projects.
Waldenstrom macroglobulinemia (WM) is present in significant cases of LPL.
Renal MALT lymphoma associated with Waldenstrom macroglobulinemia.
A bone marrow biopsy performed on this patient revealed Waldenstrom macroglobulinemia, which produces large amounts of IgM (3,4).